Aptinyx

Developer of small molecules that modulate the NMDA receptor for the treatment of CNS diseases

placeEvanston, Illinois, United States calendar_todayFounded 2015 groups37 employees language aptinyx.com

Registered entities

Investor mix

24 investors on record; lead investors include Bain Capital, New Leaf Venture Partners; 2 have since exited.

Investor typeCountShare
Venture capital1042%
Private equity833%
Bank & private debt14%
Other / undisclosed521%
Coming soon